Salarius Pharmaceuticals Cash Flow From Operations vs. EBITDA
| SLRX Stock | USD 1.52 0.15 10.95% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.89 |
|
|
For Salarius Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Salarius Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Salarius Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Salarius Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Salarius Pharmaceuticals over time as well as its relative position and ranking within its peers.
Salarius |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Salarius Pharmaceuticals. If investors know Salarius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Salarius Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.14) | Quarterly Revenue Growth (1.00) | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Salarius Pharmaceuticals is measured differently than its book value, which is the value of Salarius that is recorded on the company's balance sheet. Investors also form their own opinion of Salarius Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Salarius Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Salarius Pharmaceuticals' market value can be influenced by many factors that don't directly affect Salarius Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Salarius Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Salarius Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Salarius Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Salarius Pharmaceuticals EBITDA vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Salarius Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Salarius Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Salarius Pharmaceuticals is rated below average in cash flow from operations category among its peers. It is currently regarded as top stock in ebitda category among its peers . Salarius Pharmaceuticals reported EBITDA of (12,884.89) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Salarius Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Salarius EBITDA vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Salarius Pharmaceuticals |
| = | (12.85 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Salarius Pharmaceuticals |
| = | (12.88 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Salarius EBITDA Comparison
Salarius Pharmaceuticals is currently under evaluation in ebitda category among its peers.
Salarius Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Salarius Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Salarius Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Salarius Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Salarius Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Interest Income | 355.8 K | 441.7 K | |
| Operating Income | -12.9 K | -13.5 K | |
| Net Loss | -18 M | -18.9 M | |
| Income Before Tax | -12.5 K | -13.2 K | |
| Non Operating Income Net Other | 502.7 K | 667.5 K | |
| Total Other Income Expense Net | 352.25 | 334.64 | |
| Net Loss | -28.4 M | -27 M | |
| Net Loss | -12.5 M | -13.2 M | |
| Income Tax Expense | (1.00) | (1.05) | |
| Net Interest Income | 355.8 K | 373.6 K | |
| Change To Netincome | 13.4 M | 14.1 M | |
| Income Quality | 1.02 | 0.78 | |
| Net Income Per E B T | 0.89 | 0.75 |
Salarius Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Salarius Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Salarius Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Salarius Pharmaceuticals' important profitability drivers and their relationship over time.
Use Salarius Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Salarius Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Salarius Pharmaceuticals Pair Trading
Salarius Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Salarius Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Salarius Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Salarius Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Salarius Pharmaceuticals to buy it.
The correlation of Salarius Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Salarius Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Salarius Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Salarius Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Salarius Pharmaceuticals position
In addition to having Salarius Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Salarius Stock Analysis
When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.